IDV concentrations plummet with rifampicin.
Carter
Michael
M
D000904:Antibiotics, Antitubercular / Q000493:pharmacokinetics* / Q000627:therapeutic use; D018791:CD4 Lymphocyte Count; D004347:Drug Interactions; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000493:pharmacokinetics* / Q000627:therapeutic use; D006801:Humans; D019469:Indinavir / Q000493:pharmacokinetics* / Q000627:therapeutic use; D012293:Rifampin / Q000493:pharmacokinetics* / Q000627:therapeutic use; D014376:Tuberculosis / Q000150:complications / Q000188:drug therapy*; D019562:Viral Load
D000904:Antibiotics, Antitubercular; D017320:HIV Protease Inhibitors; D019469:Indinavir; D012293:Rifampin